BTAI vs LVS · rev $388.0K vs P/E 28, rev $6.74B
BioXcel Therapeutics Inc (BTAI) versus Las Vegas Sands Corp (LVS) — a side-by-side from cached financials, not a winner call.
BioXcel Therapeutics Inc (BTAI) is a drug manufacturers - specialty & generic company listed on US.
Las Vegas Sands Corp (LVS) is a resorts & casinos company listed on US.
Latest reported BTAI revenue for 2026-06-30 was $388.0K. Net income was -$27.4M. Revenue was up 88.3% from 2026-03-31 to 2026-06-30. BTAI currently screens at market cap $36.1M.
Latest reported LVS revenue for 2026-06-30 was $6.74B. Net income was $913.0M. Revenue was up 88.0% from 2026-03-31 to 2026-06-30. LVS currently screens at market cap $35.70B and trailing P/E 28.3.
BTAI currently screens at market cap $36.1M. LVS currently screens at market cap $35.70B and trailing P/E 28.3.
Not investment advice. Open the BTAI and LVS stock pages for the full models.
Not investment advice.